<DOC>
	<DOC>NCT00002051</DOC>
	<brief_summary>Examine the ability of thymopentin (Timunox) to: Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.</brief_summary>
	<brief_title>Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Thymopentin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Treatment: Allowed: Aerosolized pentamidine. Prior Medication: Allowed: Aerosolized pentamidine. Exclusion Criteria Coexisting Condition: Patients with the following are excluded: AIDS as defined by the CDC (except for those with HIV "wasting syndrome"). Significant hepatic disease. Thrombocytopenia (&lt; 75000 platelets/mm3). Abnormal chest xray (indicative of active disease (opportunistic infection)) within 30 days prior to entry. Hemophilia A or B or other hematologic disorders requiring current or previous administration of blood products. Known hypersensitivity to thymopentin. Prior Medication: Excluded within 30 days of study entry: Immunomodulatory or experimental therapy. Excluded within 90 days of study entry: Zidovudine (AZT). Patients must not have: AIDS as defined by the CDC (except for those with HIV "wasting syndrome"). Significant hepatic disease. Thrombocytopenia (&lt; 75000 platelets/mm3). Patients with the following conditions are included: Seropositive for HIV1 (ELISA assay) confirmed by Western blot. HIV1 p24 antigen must be detected in supernatant fluids from cocultures of patient's peripheral blood monocytes (PBMC) on two separate occasions. HIV "wasting syndrome". Must voluntarily sign consent. History of intravenous drug abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1989</verification_date>
	<keyword>Thymopentin</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>